PDA

View Full Version : FIOCRUZ Receives Regulatory Approval To Market DPP HIV 1/2 Test In Brazil



NewsWhore
07-01-2010, 10:50 AM
Chembio Diagnostics, Inc. (OTCBB: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, has been notified that Bio-Manguinhos, a division of the Oswaldo Cruz Founda...

More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/36536876/)